Vis enkel innførsel

dc.contributor.authorCui, Guanglin
dc.contributor.authorFlorholmen, Jon
dc.contributor.authorGoll, Rasmus
dc.date.accessioned2022-11-03T18:58:54Z
dc.date.available2022-11-03T18:58:54Z
dc.date.created2022-08-09T12:40:46Z
dc.date.issued2022
dc.identifier.citationCui, G., Florholmen, J. & Goll, R. (2022). Could mucosal TNF transcript as a biomarker candidate help optimize anti-TNF biological therapy in patients with ulcerative colitis? Frontiers in Immunology, 13: 11, 881112. doi:en_US
dc.identifier.issn1664-3224
dc.identifier.urihttps://hdl.handle.net/11250/3030025
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCould Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?en_US
dc.title.alternativeCould Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?en_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Authorsen_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologi: 773en_US
dc.source.pagenumber11en_US
dc.source.volume13en_US
dc.source.journalFrontiers in Immunologyen_US
dc.identifier.doi10.3389/fimmu.2022.881112
dc.identifier.cristin2041944
dc.source.articlenumber881112en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal